Login
Login     |     Register     |     Recover Username/Password

General Investing

Equinix Inc (EQIX) Solidifies Global Presence in Network-Dense Colocation Space, Eyes 2015 REIT Conversion

May 20, 2013

Equinix (EQIX) is proving to be a solid global player in the network-dense colocation space, reporting record bookings from cloud customers in its March quarter results and making acquisitions to expand into new geographies, says Todd Weller, Managing Director at Stifel, Nicolaus & Co., Inc.

“There’s been a lot of controversy recently around whether cloud is a positive or a negative driver for data center companies, and we think it is a positive driver, as we’ve talked about, and Equinix pointed out that they had record bookings from cloud customers in the quarter,” Weller said.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.

Weller is bullish on the network-dense colocation space, because it has higher barriers of entry and is less prone to impacts from increased supply in addition to being a beneficiary of secular drivers such as mobile, cloud and social media. In this space, EQIX has expanded its global presence by making small acquisitions; however, EQIX is facing challenges as it eyes a REIT transition in 2015, Weller says.

“In the network-dense colocation space, pretty much we’ve seen Equinix make smaller tuck-in acquisitions to expand into new geographies. One of the key advantages they have is they are the only global player,” Weller said. “The fundamentals there are good, and I think valuation is attractive. I think one near-term challenge from a stock perspective is that we may be in a vacuum period in terms of who the incremental buyer of the stock is, given the company is in the midst of converting to a REIT on January 1, 2015.”


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now